- •Preface and Acknowledgments
- •Contents
- •Contributors
- •1: Embryology for Urologists
- •Introduction
- •Renal Development
- •Pronephros
- •Mesonephros
- •Metanephros
- •Development of the Collecting System
- •Critical Steps in Further Development
- •Anomalies of the Kidney
- •Renal Agenesis
- •Renal Aplasia
- •Renal Hypoplasia
- •Renal Ectopia
- •Renal Fusion
- •Ureteral Development
- •Anomalies of Origin
- •Anomalies of Number
- •Incomplete Ureteral Duplication
- •Complete Ureteral Duplication
- •Ureteral Ectopia
- •Embryology of Ectopia
- •Clinical Correlation
- •Location of Ectopic Ureteral Orifices – Male (in Descending Order According to Incidence)
- •Symptoms
- •Ureteroceles
- •Congenital Ureteral Obstruction
- •Pipestem Ureter
- •Megaureter-Megacystis Syndrome
- •Prune Belly Syndrome
- •Vascular Ureteral Obstructions
- •Division of the Urogenital Sinus
- •Bladder Development
- •Urachal Anomalies
- •Cloacal Duct Anomalies
- •Other Bladder Anomalies
- •Bladder Diverticula
- •Bladder Extrophy
- •Gonadal Development
- •Testicular Differentiation
- •Ovarian Differentiation
- •Gonadal Anomalies
- •Genital Duct System
- •Disorders of Testicular Function
- •Female Ductal Development
- •Prostatic Urethral Valves
- •Gonadal Duct Anomalies
- •External Genital Development
- •Male External Genital Development
- •Female External Genital Development
- •Anomalies of the External Genitalia
- •References
- •2: Gross and Laparoscopic Anatomy of the Upper Urinary Tract and Retroperitoneum
- •Overview
- •The Kidneys
- •The Renal Vasculature
- •The Renal Collecting System
- •The Ureters
- •Retroperitoneal Lymphatics
- •Retroperitoneal Nerves
- •The Adrenal Glands
- •References
- •3: Gross and Laparoscopic Anatomy of the Lower Urinary Tract and Pelvis
- •Introduction
- •Female Pelvis
- •Male Pelvis
- •Pelvic Floor
- •Urinary Bladder
- •Urethra
- •Male Urethra
- •Female Urethra
- •Sphincter Mechanisms
- •The Bladder Neck Component
- •The Urethral Wall Component
- •The External Urethral Sphincter
- •Summary
- •References
- •4: Anatomy of the Male Reproductive System
- •Testis and Scrotum
- •Spermatogenesis
- •Hormonal Regulation of Spermatogenesis
- •Genetic Regulation of Spermatogenesis
- •Epididymis and Ductus Deferens
- •Accessory Sex Glands
- •Prostate
- •Seminal Vesicles
- •Bulbourethral Glands
- •Penis
- •Erection and Ejaculation
- •References
- •5: Imaging of the Upper Tracts
- •Anatomy of the Upper Tracts and Introduction to Imaging Modalities
- •Introduction
- •Renal Upper Tract Basic Anatomy
- •Modalities Used for Imaging the Upper Tracts
- •Ultrasound
- •Radiation Issues
- •Contrast Issues
- •Renal and Upper Tract Tumors
- •Benign Renal Tumors
- •Transitional Cell Carcinoma
- •Renal Mass Biopsy
- •Renal Stone Disease
- •Ultrasound
- •Plain Radiographs and IVU
- •Renal Cystic Disease
- •Benign Renal Cysts
- •Hereditary Renal Cystic Disease
- •Complex Renal Cysts
- •Renal Trauma
- •References
- •Introduction
- •Pathophysiology
- •Susceptibility and Resistance
- •Epidemiological Breakpoints
- •Clinical Breakpoints
- •Pharmacodynamic Parameters
- •Pharmacokinetic Parameters
- •Fosfomycin
- •Nitrofurantoin
- •Pivmecillinam
- •b-Lactam-Antibiotics
- •Penicillins
- •Cephalosporins
- •Carbapenems
- •Aminoglycosides
- •Fluoroquinolones
- •Trimethoprim, Cotrimoxazole
- •Glycopeptides
- •Linezolid
- •Conclusion
- •References
- •7: An Overview of Renal Physiology
- •Introduction
- •Body Fluid Compartments
- •Regulation of Potassium Balance
- •Regulation of Acid–Base Balance
- •Diuretics
- •Suggested Reading
- •8: Ureteral Physiology and Pharmacology
- •Ureteral Anatomy
- •Modulation of Peristalsis
- •Ureteral Pharmacology
- •Conclusion
- •References
- •Introduction
- •Afferent Signaling Pathways
- •Efferent Signaling
- •Parasympathetic Nerves
- •Sympathetic Nerves
- •Vesico-Spinal-Vesical Micturition Reflex
- •Peripheral Targets
- •Afferent Signaling Mechanisms
- •Urothelium
- •Myocytes
- •Cholinergic Receptors
- •Muscarinic Receptors
- •Nicotinic Receptors
- •Adrenergic Receptors (ARs)
- •a-Adrenoceptors
- •b-Adrenoceptors
- •Transient Receptor Potential (TRP) Receptors
- •Phosphodiesterases (PDEs)
- •CNS Targets
- •Opioid Receptors
- •Serotonin (5-HT) Mechanisms
- •g-Amino Butyric Acid (GABA) Mechanisms
- •Gabapentin
- •Neurokinin and Neurokinin Receptors
- •Summary
- •References
- •10: Pharmacology of Sexual Function
- •Introduction
- •Sexual Desire/Arousal
- •Endocrinology
- •Steroids in the Male
- •Steroids in the Female
- •Neurohormones
- •Neurotransmitters
- •Dopamine
- •Serotonin
- •Pharmacological Strategies
- •CNS Drugs
- •Enzyme-inducing Antiepileptic Drugs
- •Erectile Function
- •Ejaculatory Function
- •Premature Ejaculation
- •Abnormal Ejaculation
- •Conclusions
- •References
- •Epidemiology
- •Calcium-Based Urolithiasis
- •Uric Acid Urolithiasis
- •Infectious Urolithiasis
- •Cystine-Based Urolithiasis
- •Aims
- •Who Deserves Metabolic Evaluation?
- •Metabolic Workup for Stone Producers
- •Medical History and Physical Examination
- •Stone Analysis
- •Serum Chemistry
- •Urine Evaluation
- •Urine Cultures
- •Urinalysis
- •Twenty-Four Hour Urine Collections
- •Radiologic Imaging
- •Medical Management
- •Conservative Management
- •Increased Fluid Intake
- •Citrus Juices
- •Dietary Restrictions
- •Restricted Oxalate Diet
- •Conservative Measures
- •Selective Medical Therapy
- •Absorptive Hypercalciuria
- •Thiazide
- •Orthophosphate
- •Renal Hypercalciuria
- •Primary Hyperparathyroidism
- •Hyperuricosuric Calcium Oxalate Nephrolithiasis
- •Enteric Hyperoxaluria
- •Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Distal Renal Tubular Acidosis
- •Chronic Diarrheal States
- •Thiazide-Induced Hypocitraturia
- •Idiopathic Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Hypomagnesiuric Calcium Nephrolithiasis
- •Gouty Diathesis
- •Cystinuria
- •Infection Lithiasis
- •Summary
- •References
- •12: Molecular Biology for Urologists
- •Introduction
- •Inherited Changes in Cancer Cells
- •VEGR and Cell Signaling
- •Targeting mTOR
- •Conclusion
- •References
- •13: Chemotherapeutic Agents for Urologic Oncology
- •Introduction
- •Bladder Cancer
- •Muscle Invasive Bladder Cancer
- •Metastatic Bladder Cancer
- •Conclusion
- •Prostate Cancer
- •Other Chemotherapeutic Drugs or Combinations for Treating HRPC
- •Conclusion
- •Renal Cell Carcinoma
- •Chemotherapy
- •Immunotherapy
- •Angiogenesis Inhibitor Drugs
- •Conclusion
- •Testicular Cancer
- •Stage I Seminoma
- •Stage I non-seminomatous Germ Cell Tumours (NSGCT)
- •Metastatic Germ Cell Tumours
- •Low-Volume Metastatic Disease (Stage II A/B)
- •Advanced Metastatic Disease
- •Salvage Chemotherapy for Relapsed or Refractory Disease
- •Conclusion
- •Penile Cancer
- •Side Effects of Chemotherapy
- •Conclusion
- •References
- •14: Tumor and Transplant Immunology
- •Antibodies
- •Cytotoxic and T-helper Cells
- •Immunosuppression
- •Induction Therapy
- •Maintenance Therapy
- •Rejection
- •Posttransplant Lymphoproliferative Disease
- •Summary
- •References
- •15: Pathophysiology of Renal Obstruction
- •Causes of Renal Obstruction
- •Effects on Prenatal Development
- •Prenatal Hydronephrosis
- •Spectrum of Renal Abnormalities
- •Renal Functional Changes
- •Renal Growth/Counterbalance
- •Vascular Changes
- •Inflammatory Mediators
- •Glomerular Development Changes
- •Mechanical Stretch of Renal Tubules
- •Unilateral Versus Bilateral
- •Limitations of Animal Models
- •Future Research
- •Issues in Patient Management
- •Diagnostic Imaging
- •Ultrasound
- •Intravenous Urography
- •Antegrade Urography and the Whitaker Test
- •Nuclear Renography
- •Computed Tomography
- •Magnetic Resonance Urography
- •Hypertension
- •Postobstructive Diuresis
- •References
- •Introduction
- •The Normal Lower Urinary Tract
- •Anatomy
- •Storage Function
- •Voiding Function
- •Neural Control
- •Symptoms
- •Flow Rate and Post-void Residual
- •Voiding Cystometry
- •Male
- •Female
- •Neurourology
- •Conclusions
- •References
- •17: Urologic Endocrinology
- •The Testis
- •Normal Androgen Metabolism
- •Epidemiological Aspects
- •Prostate
- •Brain
- •Muscle Mass and Adipose Tissue
- •Bones
- •Ematopoiesis
- •Metabolism
- •Cardiovascular System
- •Clinical Assessment
- •Biochemical Assessment
- •Treatment Modalities
- •Oral Preparations
- •Parenteral Preparations
- •Transdermal Preparations
- •Side Effects and Treatment Monitoring
- •Body Composition
- •Cognitive Decline
- •Bone Metabolism
- •The Kidneys
- •Endocrine Functions of the Kidney
- •Erythropoietin
- •Calcitriol
- •Renin
- •Paraneoplastic Syndromes
- •Hypercalcemia
- •Hypertension
- •Polycythemia
- •Other Endocrine Abnormalities
- •References
- •General Physiology
- •Prostate Innervation
- •Summary
- •References
- •Wound Healing
- •Inflammation
- •Proliferation
- •Remodeling
- •Principles of Plastic Surgery
- •Tissue Characteristics
- •Grafts
- •Flap
- •References
- •Lower Urinary Tract Symptoms
- •Storage Phase
- •Voiding Phase
- •Return to Storage Phase
- •Urodynamic Parameters
- •Urodynamic Techniques
- •Volume Voided Charts
- •Pad Testing
- •Typical Test Schedule
- •Uroflowmetry
- •Post Voiding Residual
- •Further Diagnostic Evaluation of Patients
- •Cystometry with or Without Video
- •Cystometry
- •Videocystometrography (Cystometry + Cystourethrography)
- •Cystometric Findings
- •Comment:
- •Measurements During the Storage Phase:
- •Measurements During the Voiding Phase:
- •Abnormal Function
- •Disorders of Sensation
- •Causes of Hypersensitive Bladder Sensation
- •Causes of Hyposensitive Bladder Sensation
- •Disorders of Detrusor Motor Function
- •Bladder Outflow Tract Dysfunction
- •Detrusor–Urethral Dyssynergia
- •Detrusor–Bladder Neck Dyssynergia
- •Detrusor–Sphincter Dyssynergia
- •Complex Urodynamic Investigation
- •Urethral Pressure Measurement
- •Technique
- •Neurophysiological Evaluation
- •Conclusion
- •References
- •Endoscopy
- •Cystourethroscopy
- •Ureteroscopy and Ureteropyeloscopy
- •Nephroscopy
- •Virtual Reality Simulators
- •Lasers
- •Clinical Application of Lasers
- •Condylomata Acuminata
- •Urolithiasis
- •Benign Prostatic Hyperplasia
- •Ureteral and Urethral Strictures
- •Conclusion
- •References
- •Introduction
- •The Prostatitis Syndromes
- •The Scope of the Problem
- •Category III CP/CPPS
- •The Goal of Treatment
- •Conservative Management
- •Drug Therapy
- •Antibiotics
- •Anti-inflammatories
- •Alpha blockers
- •Hormone Therapies
- •Phytotherapies
- •Analgesics, muscle relaxants and neuromodulators
- •Surgery
- •A Practical Management Plan
- •References
- •Orchitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment of Infectious Orchitis
- •Epididymitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation of Epididymitis
- •Treatment of Acute Epididymitis
- •Treatment of Chronic Epididymitis
- •Treatment of Spermatic Cord Torsion
- •Fournier’s Gangrene
- •Definition and Etiology
- •Risk Factors
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment
- •References
- •Fungal Infections
- •Candidiasis
- •Aspergillosis
- •Cryptococcosis
- •Blastomycosis
- •Coccidioidomycosis
- •Histoplasmosis
- •Radiographic Findings
- •Treatment
- •Tuberculosis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Schistosomiasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Filariasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Onchocerciasis
- •References
- •25: Sexually Transmitted Infections
- •Introduction
- •STIs Associated with Genital Ulcers
- •Herpes Simplex Virus
- •Diagnosis
- •Treatment
- •Chancroid
- •Diagnosis
- •Treatment
- •Syphilis
- •Diagnosis
- •Treatment
- •Lymphogranuloma Venereum
- •Diagnosis
- •Treatment
- •Chlamydia
- •Diagnosis
- •Treatment
- •Gonorrhea
- •Diagnosis
- •Treatment
- •Trichomoniasis
- •Diagnosis
- •Treatment
- •Human Papilloma Virus
- •Diagnosis
- •Treatment
- •Scabies
- •Diagnosis
- •Treatment
- •References
- •26: Hematuria: Evaluation and Management
- •Introduction
- •Classification of Hematuria
- •Macroscopic Hematuria
- •Microscopic Hematuria
- •Dipstick Hematuria
- •Pseudohematuria
- •Factitious Hematuria
- •Menstruation
- •Aetiology
- •Malignancy
- •Urinary Calculi
- •Infection and Inflammation
- •Benign Prostatic Hyperplasia
- •Trauma
- •Drugs
- •Nephrological Causes
- •Assessment
- •History
- •Examination
- •Investigations
- •Dipstick Urinalysis
- •Cytology
- •Molecular Tests
- •Blood Tests
- •Flexible Cystoscopy
- •Upper Urinary Tract Evaluation
- •Renal USS
- •KUB Abdominal X-Ray
- •Intravenous Urography (IVU)
- •Computed Tomography (CT)
- •Retrograde Urogram Studies
- •Magnetic Resonance Imaging (MRI)
- •Additional Tests and Renal Biopsy
- •Intractable Hematuria
- •Loin Pain Hematuria Syndrome
- •References
- •27: Benign Prostatic Hyperplasia (BPH)
- •Historical Background
- •Pathophysiology
- •Patient Assessment
- •Treatment of BPH
- •Watchful Waiting
- •Drug Therapy
- •Interventional Therapies
- •Conclusions
- •References
- •28: Practical Guidelines for the Treatment of Erectile Dysfunction and Peyronie´s Disease
- •Erectile Dysfunction
- •Introduction
- •Diagnosis
- •Basic Evaluation
- •Cardiovascular System and Sexual Activity
- •Optional Tests
- •Treatment
- •Medical Treatment
- •Oral Agents
- •Phosphodiesterase Type 5 (PDE 5) Inhibitors
- •Nonresponders to PDE5 Inhibitors
- •Apomorphine SL
- •Yohimbine
- •Intracavernosal and Intraurethral Therapy
- •Intracavernosal Injection (ICI) Therapy
- •Intraurethral Therapy
- •Vacuum Constriction Devices
- •Surgical Therapy
- •Conclusion
- •Peyronie´s Disease (PD)
- •Introduction
- •Oral Drug Therapy
- •Intralesional Drug Therapy
- •Iontophoresis
- •Radiation Therapy
- •Surgical Therapy
- •References
- •29: Premature Ejaculation
- •Introduction
- •Epidemiology
- •Defining Premature Ejaculation
- •Voluntary Control
- •Sexual Satisfaction
- •Distress
- •Psychosexual Counseling
- •Pharmacological Treatment
- •On-Demand Treatment with Tramadol
- •Topical Anesthetics
- •Phosphodiesterase Inhibitors
- •Surgery
- •Conclusion
- •References
- •30: The Role of Interventional Management for Urinary Tract Calculi
- •Contraindications to ESWL
- •Complications of ESWL
- •PCNL Access
- •Instrumentation for PCNL
- •Nephrostomy Drains Post PCNL
- •Contraindications to PCNL
- •Complications of PCNL
- •Semirigid Ureteroscopy
- •Flexible Ureteroscopy
- •Electrohydraulic Lithotripsy (EHL)
- •Ultrasound
- •Ballistic Lithotripsy
- •Laser Lithotripsy
- •Ureteric Stents
- •Staghorn Calculi
- •Lower Pole Stones
- •Horseshoe Kidneys and Stones
- •Calyceal Diverticula Stones
- •Stones and PUJ Obstruction
- •Treatment of Ureteric Colic
- •Medical Expulsive Therapy (MET)
- •Intervention for Ureteric Stones
- •Stones in Pregnancy
- •Morbid Obesity
- •References
- •Anatomy and Function
- •Pathophysiology
- •Management
- •Optical Urethrotomy/Dilatation
- •Urethral Stents
- •Preoperative Assessment
- •Urethroplasty
- •Anastomotic Urethroplasty
- •Substitution Urethroplasty
- •Grafts Versus Flaps
- •Oral Mucosal Grafts
- •Tissue Engineering
- •Graft Position
- •Conclusion
- •References
- •32: Urinary Incontinence
- •Epidemiology and Risk Factors
- •Pathophysiology
- •Urge Incontinence
- •Conservative Treatments
- •Pharmacotherapy
- •Invasive/ Surgical Therapies
- •Stress Urinary Incontinence
- •Male SUI Therapies
- •Female SUI Therapies
- •Mixed Urinary Incontinence
- •Conclusions
- •References
- •33: Neurogenic Bladder
- •Introduction
- •Examination and Diagnostic Tests
- •History and Physical Examination
- •Imaging
- •Urodynamics (UDS)
- •Evoked Potentials
- •Classifications
- •Somatic Pathways
- •Brain Lesions
- •Cerebrovascular Accident (CVA)
- •Parkinson’s Disease (PD)
- •Multiple Sclerosis
- •Huntington’s Disease
- •Dementias
- •Normal Pressure Hydrocephalus (NPH)
- •Tumors
- •Psychiatric Disorders
- •Spinal Lesions and Pathology
- •Intervertebral Disk Prolapse
- •Spinal Cord Injury (SCI)
- •Transverse Myelitis
- •Peripheral Neuropathies
- •Metabolic Neuropathies
- •Pelvic Surgery
- •Treatment
- •Summary
- •References
- •34: Pelvic Prolapse
- •Introduction
- •Epidemiology
- •Anatomy and Pathophysiology
- •Evaluation and Diagnosis
- •Outcome Measures
- •Imaging
- •Urodynamics
- •Indications for Management
- •Biosynthetics
- •Surgical Management
- •Anterior Compartment Repair
- •Uterine/Apical Prolapse
- •Enterocele Repair
- •Conclusion
- •References
- •35: Urinary Tract Fistula
- •Introduction
- •Urogynecologic Fistula
- •Vesicovaginal Fistula
- •Etiology and Risk Factors
- •Clinical Factors
- •Evaluation and Diagnosis
- •Pelvic Examination
- •Cystoscopy
- •Imaging
- •Treatment
- •Conservative Management
- •Surgical Management
- •Urethrovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Ureterovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Vesicouterine Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Uro-Enteric Fistula
- •Vesicoenteric Fistula
- •Pyeloenteric Fistula
- •Urethrorectal Fistula
- •References
- •36: Urologic Trauma
- •Introduction
- •Kidney
- •Expectant Management
- •Endovascular Therapy
- •Operative Intervention
- •Operative Management: Follow-up
- •Reno-Vascular Injuries
- •Pediatric Renal Injuries
- •Adrenal
- •Ureter
- •Diagnosis
- •Treatment
- •Delayed Diagnosis
- •Bladder and Posterior Urethra
- •Bladder Injuries: Initial Management
- •Bladder Injuries: Formal Repair
- •Anterior Urethral Trauma
- •Fractured Penis
- •Penile Amputation
- •Scrotal and Testicular Trauma
- •Imaging
- •CT-IVP (CT with Delayed Images)
- •Technique
- •Cystogram
- •Technique
- •Retrograde Urethrogram (RUG)
- •Technique
- •Retrograde Pyelogram (RPG)
- •Technique
- •One-Shot IVP
- •Technique
- •References
- •37: Bladder Cancer
- •Who Should Be Investigated?
- •Epidemiology
- •Risk Factors
- •Role of Screening
- •Signs and Symptoms
- •Imaging
- •Cystoscopy
- •Urine Tests
- •PDD-Assisted TUR
- •Pathology
- •NMIBC and Risk Groups
- •Intravesical Chemotherapy
- •Intravesical Immunotherapy
- •Immediate Cystectomy and CIS
- •Radical Cystectomy with Pelvic Lymph Node Dissection
- •sexual function-preserving techniques
- •Bladder-Preservation Treatments
- •Neoadjuvant Chemotherapy
- •Adjuvant Chemotherapy
- •Preoperative Radiotherapy
- •Follow-up After TUR in NMIBC
- •References
- •38: Prostate Cancer
- •Introduction
- •Epidemiology
- •Race
- •Geographic Variation
- •Risk Factors and Prevention
- •Family History
- •Diet and Lifestyle
- •Prevention
- •Screening and Diagnosis
- •Current Screening Recommendations
- •Biopsy
- •Pathology
- •Prognosis
- •Treatment of Prostate Cancer
- •Treatment for Localized Prostate Cancer (T1, T2)
- •Radical Prostatectomy
- •EBRT
- •IMRT
- •Brachytherapy
- •Treatment for Locally Advanced Prostate Cancer (T3, T4)
- •EBRT with ADT
- •Radical Prostatectomy
- •Androgen-Deprivation Therapy
- •Summary
- •References
- •39: The Management of Testis Cancer
- •Presentation and Diagnosis
- •Serum Tumor Markers
- •Primary Surgery
- •Testis Preserving Surgery
- •Risk Stratification
- •Surveillance Versus Primary RPLND
- •Primary RPLND
- •Adjuvant Treatment for High Risk
- •Clinical Stage 1 Seminoma
- •Risk-Stratified Adjuvant Treatment
- •Adjuvant Radiotherapy
- •Adjuvant Low Dose Chemotherapy
- •Primary Combination Chemotherapy
- •Late Toxicity
- •Salvage Strategies
- •Conclusion
- •References
- •Index
|
|
|
|
290 |
|
|
|
|
|
|
|
|
|
|
|
Practical Urology: EssEntial PrinciPlEs and PracticE |
|
Ureteral and Urethral Strictures |
|
pathophysiologies, the indications for laser |
|||
Ureteropelvic |
junction obstruction, |
ureteral |
therapy in minimally invasive urologic surgery |
||
will continue to expand. |
|||||
strictures, uretero-enteric structures, urethral |
|||||
|
|||||
strictures, and bladder neck contractures have |
References |
||||
allbeentreatedusinglasertechnology.Minimally |
|||||
invasive techniques for ureteral strictures have |
|
||||
come to be the first-line therapy. Specifically, the |
1. Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters |
||||
holmium:YAG laser is often used to treat ure- |
CA. Chapter 6 Basic instrumentation and cystoscopy. |
||||
teral strictures due to its good safety profile, pre- |
In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, |
||||
cision,incision capability,and minimal collateral |
Peters CA, eds. Campbell-Walsh Urology. 9th ed. |
||||
injury. In addition, it is compatible with multiple |
Philadelphia, PA: Saunders Elsevier; 2007:168-70 |
||||
flexible endoscopes providing excellent multi- |
2. Borin JF, Abdelshehid CS, Clayman RV. Comparison |
||||
functionality. A ureterotomy incision should be |
of resolution, contrast, and color differentiation |
||||
made from the ureteral lumen to the periureteral |
among fiberoptic and digital flexible cystoscopes. J |
||||
Endourol. 2006;20(1):54-58 |
|||||
fat in a full thickness fashion. The holmium laser |
|||||
3. Preminger GM, Tiselius HG, Assimos DG, et al. 2007 |
|||||
pulse energy |
and frequency are commonly |
||||
guideline for management of ureteral calculi. J Urol. |
|||||
placed at 1 J and 10–15 Hz to make an adequate |
|||||
2007;178:2418-34 |
|||||
incision.35,36 Ho:YAG laser endoureterotomy has |
4. Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters |
||||
been shown to have adequate durability for |
CA. Chapter 45 Ureteroscopy and retrograde ure- |
||||
benign ureteral strictures, ureteropelvic junc- |
teral access. In: Wein AJ, Kavoussi LR, Novick AC, |
||||
tion, and uretero-enteric strictures than previ- |
Partin AW, Peters CA, eds. Campbell-Walsh Urology. |
||||
ously accepted minimally invasive modalities, |
9th ed. Philadelphia, PA: Saunders Elsevier; 2007: |
||||
such as balloon dilation.37-39 |
|
1508 |
|||
Nd:YAG, KTP, and holmium have treated ure- |
5. Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters |
||||
CA. Chapter 43 Evaluation and medical management |
|||||
thral strictures. Ideally, the type of laser used |
|||||
of urinary lithiasis. In: Wein AJ, Kavoussi LR, Novick |
|||||
should vaporize the tissue and exhibit negligible |
|||||
AC, Partin AW, Peters CA, eds. Campbell-Walsh |
|||||
peripheral tissue damage. Nd:YAG laser core- |
|||||
Urology. 9th ed. Philadelphia, PA: Saunders Elsevier; |
|||||
through urethrotomy has been shown to be |
2007:1433 |
||||
effective for post-traumatic urethral strictures.40 |
6. Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters |
||||
However, the drawbacks to using the Nd:YAG |
CA. Chapter 49 Management of urothelial tumors of |
||||
laser is that it causes thermal necrosis, which |
the renal pelvis and ureter. In: Wein AJ, Kavoussi LR, |
||||
can lead to significant peripheral tissue injury. |
Novick AC, Partin AW, Peters CA, eds. Campbell- |
||||
The KTP laser has less penetration than Nd:YAG, |
Walsh Urology. 9th ed. Philadelphia, PA: Saunders |
||||
but at the same time is less effective for dense |
Elsevier; 2007:1674 |
||||
7. Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters |
|||||
strictures. The |
holmium:YAG laser |
has been |
|||
CA. Chapter 44 Surgical management of upper uri- |
|||||
shown to be the laser of choice for urethral stric- |
|||||
nary tract calculi. In: Wein AJ, Kavoussi LR, Novick |
|||||
tures.41 It provides both direct contact cutting |
|||||
AC, Partin AW, Peters CA, eds. Campbell-Walsh |
|||||
and vaporization with minimal forward scatter. |
Urology. 9th ed. Philadelphia, PA: Saunders Elsevier; |
||||
To date, the results of laser urethrotomy have |
2007:1489 |
||||
varied durability and the technology may be |
8. Beaghler MA, Poon MW, Dushinski JW, Lingeman JE. |
||||
best for small isolated strictures. |
|
Expanding role of flexible nephroscopy in the upper |
|||
|
|
|
|
urinary tract. J Endourol. 1999;13(2):93-7 |
|
Conclusion |
|
9. Nedas T, Challacombe B, Dasgupta P. Virtual reality |
|||
|
in urology. BJU Int. 2004;93:255-7 |
||||
|
|
|
|
10. Kuo RL, Delvecchio FC, Preminger GM. Virtual real- |
|
Laser-based therapies are firmly entrenched in |
ity: current urologic applications and future devel- |
||||
the armamentarium of modern urologic sur- |
opments. J Endourol. 2001;15:117-22 |
||||
11. Reich O, Noll M, Gratze C, et al. High-level virtual |
|||||
gery and, in some cases, have revolutionized |
|||||
reality simulator for endourologic procedures of |
|||||
the treatment of urologic disorders including |
|||||
lower urinary tract. Urology. 2006;67:1144-8 |
|||||
urolithiasis, BPH, stricture disease, and transi- |
|||||
12. Shah J, Darzi A. Virtual reality flexible cystoscopy: a |
|||||
tional cell carcinoma of the ureter and bladder. |
|||||
validation study. BJU Int. 2002;90:828-32 |
|||||
With new technological advances and contin- |
13. Chou DS,Abdelshehid C,Clayman RV,McDougall EM. |
||||
ued understanding of the underlying disease |
Comparison of results of Virtual-reality simulators |
291
Urologic instrUmEntation: EndoscoPEs and lasErs
|
and training model for basic urertoscopy training. |
29. |
Johnson DE, Cromeens DM, Price RE. Use of |
|
J Endourol. 2006;20:266-71 |
|
holmium:YAG laser in urology. Lasers Surg Med. |
14. |
Gross AJ, Herrmann TR. History of lasers. World J |
|
1992;12:353 |
|
Urol. 2007;25(3):217-20 |
30. |
Gilling PJ, Cass CB, Cresswell MD. Holmium laser |
15. |
Grasso M, Green D. Lasers in urology. E Medicine. |
|
resection of the prostate: preliminary results of a new |
|
2008 http://emedicine.medscape.com |
|
method for the treatment of benign prostatic hyper- |
16. |
Schaeffer AJ. Use of the CO2 laser in urology. Urol |
31. |
plasia. Urology. 1996;47(1):48-51 |
|
Clin North Am. 1986;3:393-404 |
Gilling PJ. Holmium laser enucleation of the prostate. |
|
17. |
Floratos DL, de la Rosette JJ. Lasers in urology. BJU |
|
BJU Int. 2008;101:131-42 |
|
Int. 1999;84(2):204-11 |
32. |
Tan AHH, Gilling PJ, Kennett KM, et al. A random- |
18. |
Grocela JA, Dretler SP. Intracorporeal lithotripsy. |
|
ized trial comparing holmium laser enucleation of |
|
Instrumentation and development. Urol Clin North |
|
the prostate with transurethral resection of the pros- |
|
Am. 1997;24(1):13-23 |
|
tate for the treatment of bladder outlet obstruction |
19. |
Wein AJ, Kavoussi LR, Novick AC, Partin AW, |
|
secondary to benign prostatic hyperplasia in large |
|
Peters CA. Chapter 45 Ureteroscopy and retrograde |
|
glands (40–200 g). J Urol. 2003;170:1270-4 |
|
ureteral access. In: Wein AJ, Kavoussi LR, Novick AC, |
33. Kuntz RM,Lehrich K,Ahyai SA.Holmium laser enucle- |
|
|
Partin AW, Peters CA, eds. Campbell-Walsh Urology. |
|
ation of the prostate versus open prostatectomy for |
|
Philadelphia, PA: Saunders Elsevier; 2007:1460 |
|
prostates greater than 100 g: 5 years follow-up results of |
20. |
Dushinski JW, Lingeman JE. High-speed photo- |
|
a randomised clinical trial. Eur Urol. 2008;53(1):160-6 |
|
graphic evaluation of the holumium laser.J Endourol. |
34. |
Shah HN, Mahajan AP, Sodha HS, et al. Prospective |
|
1998;12(2):177-81 |
|
evaluation of the learning curve for holmium laser |
21. |
Vassar GJ,Chan KF,Teichman JM,et al.Holmium:YAG |
|
enucleation of the prostate. J Urol. 2007;177:1468-74 |
|
lithotripsy: photothermal mechanism. J Endourol. |
35. |
Knudsen BE, Cook AJ, Watterson JD, et al. Percutane- |
|
1999;13(3):181-190 |
|
ous antegrade endopyelotomy: long-term results from |
22. |
Wollin TA, Denstedt JD. The holmium laser in urol- |
|
one institution. Urology. 2004;63(2):230-4 |
|
ogy. J Clin Laser Med Surg. 1998;16:13-20 |
36. |
Springhart WP, Preminger GM. Chapter 11 Retro- |
23. |
Santa-Cruz RW, Leveillee RJ, Kronrad A. Ex vivo |
|
grade endopyelotomy. In: Nakada SY, Pearle MS, eds. |
|
comparison of four lithotripters commonly used in |
|
Advanced Endourology: The Complete Clinical Guide. |
|
the ureter: what does it take to perforate? J Endourol. |
|
Totowa, NJ: Humana Press; 2006:183-95 |
|
1998;12(5):417-22 |
37. |
Watterson JD,Sofer M,Wollin TA,et al.Holmium:YAG |
24. |
Scarpa RM, De Lisa A, Porru D, et al. Holmium:YAG |
|
laser endoureterotomy for ureterointestinal stric- |
|
laser ureterolithotripsy. Eur Urol. 1999;35:233-8 |
|
tures. J Urol. 2002;167:1692-5 |
25. |
Gomella LG, Lofti MA, Rivas DA, et al. Contact laser |
38. |
Hibi H, Ohori T, Taki T, et al. Long-term results of |
|
vaporization techniques for benign prostatic hyper- |
|
endoureterotomy using a holmium laser. Int J Urol. |
|
plasia. J Endourol. 1995;9:117-23 |
|
2007;14:872-4 |
26. |
Wang X, Chen J, Jiao D et al. The beam characteristic |
39. |
Lane BR, Desai MM, Hegarty NJ, Streem SB. Long- |
|
of Nd:YAG frequency doubling in a KTP crystal by |
|
term efficacy of holmium laser endoureterotomy for |
|
the resonant external ring cavity. Nonlinear Optical |
|
benign ureteral strictures. Urology. 2006;67:894-7 |
|
Phenomena and Applications. Proc SPIE. 2005;5646: |
40. |
Dogra PN, Nabi G. Core-through urethrotomy using |
|
636-642 |
|
the neodymium:YAG laser for obliterative urethral |
27. |
Reich O, Bachmann A, Siebels M, et al. High power |
|
strictures after traumatic urethral disruption and/or |
|
(80 W) potassium-titanyl-phosphate laser vaporiza- |
|
distraction defects: long-term outcome. J Urol. |
|
tion of the prostate in 66 high risk patients. J Urol. |
|
2002;167:543-6 |
|
2005;173:158-60 |
41. |
Kamp S, Knoll T, Osman MM, et al. Low-power |
28. |
Gilling PJ, Cass CB, Malcolm AR, et al. Combination |
|
holmium:YAG laser urethrotomy for treatment of |
|
holmium and Nd:YAG laser ablation of the prostate: |
|
urethral strictures: functional outcome and quality |
|
initial clinical experience. J Endourol. 1995;9:151 |
|
of life. J Endourol. 2006;20:38-41 |
Part II
Clinical Urologic Practice